Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Law Office Of Brodsky & Smith Reveals Investigation Of EResearch Technology

Law office of Brodsky & Smith LLC said Saturday it is investigating potential claims against the Board of Directors of eResearchTechnology Inc. (ERT: Quote) relating to the proposed acquisition by Genstar Capital.

Under the terms of the transaction, eResearch shareholders would receive only $8.00 in cash for each share of eResearch stock they own. According to Brodsky & Smith, the investigation concerns possible breaches of fiduciary duty and other violations of state law by the Board of eResearch for not acting in the shareholders' interests in connection with the sale process to Genstar.

Brodsky & Smith said the transaction may undervalue eResearch as eResearch stock traded at $8.11 as recently as April 3, 2012. In addition, an analyst has set a price target on eResearch stock at $9.00 per share, it added.

Pennsylvania-based eResearch Technology Inc. provides technology-driven services and medical devices primarily in North America, the United Kingdom, and Germany.

Click here to receive FREE breaking news email alerts for eResearchTechnology Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Toyota Motor Corp. (TM, TYT.L) Thursday announced 1.1 percent decline in worldwide production for October, as there was a sharp decline in production of passenger cars in Japan. Production outside Japan improved 2.3 percent. In a separate announcement, the Japanese automaker said it will recall more... Computer and printer maker Hewlett-Packard Co. said Tuesday after the markets closed that its fourth quarter profit fell 6% from last year, as revenue declined 2%. The company's quarterly earnings per share, excluding items, came in line with analysts' expectations, but its quarterly revenue fell short of analysts' forecast. This organic and natural products company has experienced strong compounded annual growth over the last four fiscal years with its net sales growing 25% and adjusted income from continuing operations over 30%.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.